Skip to main content

Advertisement

SpringerLink
Log in

Paraneoplastic movement disorders

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Neurologic paraneoplastic syndromes (NPSs) result from damage to the nervous system due to the remote effects of cancer not related to metastasis, infection, or metabolic derangements. NPSs are rare, affecting 1 in 10,000 patients with cancer. Pathogenesis is likely related to the immune mechanisms: normal neural tissue is mistakenly attacked due to the similarity in the onconeural antigens expressed by the tumor cells. Among the various “classic” and other NPSs, this review focuses on paraneoplastic movement disorders, including ataxia due to cerebellar degeneration, stiffperson syndrome, opsoclonus-myoclonus syndrome, chorea, parkinsonism, and tremor. The recently described syndrome of paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis is also included, given that these patients have complex movements such as stereotypies and dyskinesias in addition to psychiatric symptoms, altered sensorium, and other neurologic signs. Although variable, treatment and prognosis of NPSs rely heavily on treatment of the underlying malignancy and immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Poser JB: Paraneoplastic syndromes. Rev Neurol (Paris) 2002, 158:899–906.

    Google Scholar 

  2. Darnell RB, Posner JB: Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003, 349:1543–1554.

    Article  PubMed  CAS  Google Scholar 

  3. Honnorat J, Antoine JC: Paraneoplastic neurological syndromes. Orphanet J Rare Dis 2007, 2:22.

    Article  PubMed  Google Scholar 

  4. Drlicek M, Bianchi G, Bogliun G, et al.: Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J Neurol 1997, 244:85–89.

    Article  PubMed  CAS  Google Scholar 

  5. Graus F, Delattre JY, Antoine JC, et al.: Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004, 75:1135–1140.

    Article  PubMed  CAS  Google Scholar 

  6. Dalmau J, Gonzalez RG, Lerwill MF: Case records of the Massachusetts General Hospital. Case 4-2007. A 56-year-old woman with rapidly progressive vertigo and ataxia. N Engl J Med 2007, 356:612–620.

    Article  PubMed  CAS  Google Scholar 

  7. Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol 2008, 7:327–340.

    Article  PubMed  Google Scholar 

  8. Aye MM, Kasai T, Tashiro Y, et al.: CD8 positive T-cell infiltration in the dentate nucleus of paraneoplastic cerebellar degeneration. J Neuroimmunol 2009, 208:136–140.

    Article  PubMed  CAS  Google Scholar 

  9. Toothaker TB, Rubin M: Paraneoplastic neurological syndromes: a review. Neurologist 2009, 15:21–33.

    Article  PubMed  Google Scholar 

  10. Phuphanich S, Brock C: Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody. J Neurooncol 2007, 81:67–69.

    Article  PubMed  CAS  Google Scholar 

  11. Widdess-Walsh P, Tavee JO, Schuele S, Stevens GH: Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature. J Neurooncol 2003, 63:187–190.

    Article  PubMed  Google Scholar 

  12. Bernal F, Shams’ili S, Rojas I, et al.: Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology 2003, 60:230–234.

    PubMed  CAS  Google Scholar 

  13. Shams’ili S, Grefkens J, de Leeuw B, et al.: Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003, 126(Pt 6):1409–1418.

    Article  PubMed  Google Scholar 

  14. Honnorat J, Cartalat-Carel S, Ricard D, et al.: Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 2009, 80:412–416.

    Article  PubMed  CAS  Google Scholar 

  15. Esposito M, Penza P, Orefice G, et al.: Successful treatment of paraneoplastic cerebellar degeneration with rituximab. J Neurooncol 2008, 86:363–364.

    Article  PubMed  Google Scholar 

  16. Kraemer M, Berlit P: Progressive encephalomyelitis with rigidity and myoclonus in an 81-year-old patient. Clin Neurol Neurosurg 2008, 110:279–281.

    Article  PubMed  Google Scholar 

  17. De Camilli P, Thomas A, Cofiell R, et al.: The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med 1993, 178:2219–2223.

    Article  PubMed  Google Scholar 

  18. Murinson BB, Guarnaccia JB: Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology 2008, 71:1955–1958.

    Article  PubMed  CAS  Google Scholar 

  19. Nguyen-Huu BK, Urban PP, Schreckenberger M, et al.: Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer. Mov Disord 2006, 21:1285–1287.

    Article  PubMed  CAS  Google Scholar 

  20. McHugh JC, Murray B, Renganathan R, et al.: GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma. Mov Disord 2007, 22:1343–1346.

    Article  PubMed  Google Scholar 

  21. McCabe DJ, Turner NC, Chao D, et al.: Paraneoplastic “stiff person syndrome” with metastatic adenocarcinoma and anti-Ri antibodies. Neurology 2004, 62:1402–1404.

    PubMed  CAS  Google Scholar 

  22. Butler MH, Hayashi A, Ohkoshi N, et al.: Autoimmunity to gephyrin in stiff-man syndrome. Neuron 2000, 26:307–312.

    Article  PubMed  CAS  Google Scholar 

  23. Tate ED, Allison TJ, Pranzatelli MR, Verhulst SJ: Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs 2005, 22:8–19.

    Article  PubMed  Google Scholar 

  24. Kirsten A, Beck S, Fühlhuber V, et al.: New autoantibodies in pediatric opsoclonus myoclonus syndrome. Ann N Y Acad Sci 2007, 1110:256–260.

    Article  PubMed  CAS  Google Scholar 

  25. Wong A: An update on opsoclonus. Curr Opin Neurol 2007, 20:25–31.

    Article  PubMed  CAS  Google Scholar 

  26. Kumar A, Lajara-Nanson WA, Neilson RW Jr: Paraneoplastic opsoclonus-myoclonus syndrome: initial presentation of non-Hodgkins lymphoma. J Neurooncol 2005, 73:43–45.

    Article  PubMed  Google Scholar 

  27. Bataller L, Graus F, Saiz A, et al.: Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 2001, 124:437–443.

    Article  PubMed  CAS  Google Scholar 

  28. Gabaldon-Torres L, Fernandez-Dominguez J, Salas-Felipe J, et al.: Opsoclonus-myoclonus-ataxia syndrome: two anatomoclinical case reports. Rev Neurol 2009, 48:137–140.

    PubMed  CAS  Google Scholar 

  29. Fitzpatrick AS, Gray OM, McConville J, McDonnell GV: Opsoclonus-myoclonus syndrome associated with benign ovarian teratoma. Neurology 2008, 70:1292–1293.

    Article  PubMed  CAS  Google Scholar 

  30. Jung KY, Youn J, Chung CS: Opsoclonus-myoclonus syndrome in an adult with malignant melanoma. J Neurol 2006, 253:942–943.

    Article  PubMed  Google Scholar 

  31. Van Diest D, De Raeve H, Claes J, et al.: Paraneoplastic opsoclonus-myoclonus-ataxia (OMA) syndrome in an adult patient with esthesioneuroblastoma. J Neurol 2008, 255:594–596.

    Article  PubMed  Google Scholar 

  32. Straube A, Leigh RJ, Bronstein A, et al.: EFNS task force—therapy of nystagmus and oscillopsia. Eur J Neurol 2004, 11:83–89.

    Article  PubMed  CAS  Google Scholar 

  33. Vernino S, Tuite P, Adler CH, et al.: Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 2002, 51:625–630.

    Article  PubMed  Google Scholar 

  34. Krolak-Salmon P, Androdias G, Meyronet D, et al.: Slow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies. Eur J Neurol 2006, 13:307–308.

    Article  PubMed  CAS  Google Scholar 

  35. Kinirons P, Fulton A, Keoghan M, et al.: Paraneoplastic limbic encephalitis (PLE) and chorea associated with CRMP-5 neuronal antibody. Neurology 2003, 61:1623–1624.

    PubMed  CAS  Google Scholar 

  36. Yu Z, Kryzer TJ, Griesmann GE, et al.: CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001, 49:146–154.

    Article  PubMed  CAS  Google Scholar 

  37. Nuti A, Ceravolo R, Salvetti S, et al.: Paraneoplastic choreic syndrome during non-Hodgkin’s lymphoma. Mov Disord 2000, 15:350–352.

    Article  PubMed  CAS  Google Scholar 

  38. Kellinghaus C, Kraus J, Blaes F, et al.: CRMP-5-autoantibodies in testicular cancer associated with limbic encephalitis and choreiform dyskinesias. Eur Neurol 2007, 57:241–243.

    Article  PubMed  Google Scholar 

  39. Kujawa KA, Niemi VR, Tomasi MA, et al.: Ballistic-choreic movements as the presenting feature of renal cancer. Arch Neurol 2001, 58:1133–1135.

    Article  PubMed  CAS  Google Scholar 

  40. Dorban S, Gille M, Kessler R, et al.: Chorea-athetosis in the anti-Hu syndrome. Rev Neurol (Paris) 2004, 160:126–129.

    CAS  Google Scholar 

  41. Tremont-Lukats IW, Fuller GN, Ribalta T, et al.: Paraneoplastic chorea: case study with autopsy confirmation. Neuro Oncol 2002, 4:192–195.

    PubMed  Google Scholar 

  42. Golbe LI, Miller DC, Duvoisin RC: Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism. Mov Disord 1989, 4:147–152.

    Article  PubMed  CAS  Google Scholar 

  43. Mousa AR, Al-Din AN: Neurological and cardiac complications of carcinoma of the breast. Case report. Acta Neurol Scand 1985, 72:518–521.

    Article  PubMed  CAS  Google Scholar 

  44. Fahn S, Brin MF, Dwork AJ, et al.: Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma. Mov Disord 1996, 11:298–310.

    Article  PubMed  CAS  Google Scholar 

  45. Tan JH, Goh BC, Tambyah PA, Wilder-Smith E: Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma. Parkinsonism Relat Disord 2005, 11:187–191.

    Article  PubMed  CAS  Google Scholar 

  46. Jankovic J: Progressive supranuclear palsy: paraneoplastic effect of bronchial carcinoma. Neurology 1985, 35:446–447.

    PubMed  CAS  Google Scholar 

  47. Valentino P, Labate A, Pirritano D, et al.: Orolingual tremor as unusual presentation of anti-Hu paraneoplastic syndrome. Mov Disord 2008, 23:1791–1792.

    Article  PubMed  Google Scholar 

  48. Gilhuis HJ, van Ommen HJ, Pannekoek BJ, et al.: Paraneoplastic orthostatic tremor associated with small cell lung cancer. Eur Neurol 2005, 54:225–226.

    Article  PubMed  CAS  Google Scholar 

  49. Simonetti F, Pergami P, Aktipi KM, et al.: Paraneoplastic “rubral” tremor: a case report. Mov Disord 1998, 13:612–614.

    Article  PubMed  CAS  Google Scholar 

  50. Dalmau J, Gleichman AJ, Hughes EG, et al.: Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091–1098.

    Article  PubMed  CAS  Google Scholar 

  51. Eker A, Saka E, Dalmau J, et al.: Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry 2008, 79:1082–1083.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Movement Disorders Program, 1429 Harper Street, HF-1121, Augusta, GA, 30912, USA

    Shyamal H. Mehta

Authors
  1. Shyamal H. Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John C. Morgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kapil D. Sethi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shyamal H. Mehta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mehta, S.H., Morgan, J.C. & Sethi, K.D. Paraneoplastic movement disorders. Curr Neurol Neurosci Rep 9, 285–291 (2009). https://doi.org/10.1007/s11910-009-0043-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-009-0043-4

Keywords

Search

Navigation